Analgesic Efficiency of SIPSPB vs ICNB in VATS Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorKocaeli City Hospital

About this trial

This study aims to evaluate the effectiveness of Serratus Posterior Superior Intercostal Plane (SPSIP) block compared to Intercostal Nerve (ICN) block in terms of postoperative pain control, reduction of opioid analgesic consumption, minimization of postoperative respiratory complications, and increase patient satisfaction (using a 5-point Likert scale) in patients undergoing video-assisted thoracoscopic surgery (VATS).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-80 years,

American Society of Anesthesiologists (ASA) physical status I-III

Patients who have provided informed consent to participate in the study

Disqualifiers

Patients who refuse to participate in the study by not signing the informed consent

Patients classified as ASA > 3, according to the system established by the American Society of Anesthesiologists

Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia

Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia

Trial population

Patients who will undergo elective VATS surgery in the thoracic surgery operating room of Kocaeli City Hospital

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

80 Participants
are grouped into 2 trial groups
Group A: Group SPSIP Block
Group B: Group ICN Block

Trial outcomes

Primary outcomes

1

Postoperative pain intensity

In both study groups, postoperative pain intensity at rest and with coughing was measured using the Numerical Pain Rating Scale (NPRS), a numerical scale ranging from 0 to 10 (0 meaning no pain, 10 meaning the most severe pain imaginable).

Time frame
24 hours after the end of surgery

Secondary outcomes

1

Total opioid drug consumption

The total amount of opioid doses administered via a Patient Controlled Analgesia (PCA) device in the first 24 hours after surgery

Time frame
24 hours after the end of surgery
2

Consumption of rescue analgesics

The total dose of dexketoprofen required by the patient during each specified time interval in the first 24 hours after surgery.

Time frame
24 hours after the end of surgery
3

Postoperative Complications

Postoperative complications such as nausea, vomiting or other adverse events will be recorded

Time frame
24 hours after the end of surgery
4

Patient satisfaction score

evaluated using a 5-point Likert scale (1=very dissatisfied, 5=very satisfied)

Time frame
At the 24th hour post-operation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.